- Home
- AGIO vs UTF Comparison
AGIO vs UTF Comparison
Compare AGIO & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- UTF
- Stock Information
- Founded
- AGIO 2007
- UTF 2004
- Country
- AGIO United States
- UTF United States
- Employees
- AGIO N/A
- UTF N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- UTF Finance Companies
- Sector
- AGIO Health Care
- UTF Finance
- Exchange
- AGIO Nasdaq
- UTF Nasdaq
- Market Cap
- AGIO 3.0B
- UTF 2.4B
- IPO Year
- AGIO 2013
- UTF N/A
- Fundamental
- Price
- AGIO $55.68
- UTF $25.82
- Analyst Decision
- AGIO Buy
- UTF
- Analyst Count
- AGIO 7
- UTF 0
- Target Price
- AGIO $52.33
- UTF N/A
- AVG Volume (30 Days)
- AGIO 740.7K
- UTF 266.0K
- Earning Date
- AGIO 10-31-2024
- UTF 01-01-0001
- Dividend Yield
- AGIO N/A
- UTF 8.21%
- EPS Growth
- AGIO N/A
- UTF N/A
- EPS
- AGIO 11.80
- UTF N/A
- Revenue
- AGIO $32,871,000.00
- UTF N/A
- Revenue This Year
- AGIO $33.38
- UTF N/A
- Revenue Next Year
- AGIO $163.06
- UTF N/A
- P/E Ratio
- AGIO $4.72
- UTF N/A
- Revenue Growth
- AGIO 36.79
- UTF N/A
- 52 Week Low
- AGIO $20.96
- UTF $18.15
- 52 Week High
- AGIO $62.58
- UTF $24.49
- Technical
- Relative Strength Index (RSI)
- AGIO 62.44
- UTF 60.35
- Support Level
- AGIO $52.09
- UTF $24.82
- Resistance Level
- AGIO $62.58
- UTF $25.58
- Average True Range (ATR)
- AGIO 2.91
- UTF 0.30
- MACD
- AGIO -0.11
- UTF 0.08
- Stochastic Oscillator
- AGIO 64.30
- UTF 97.10
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About UTF Cohen & Steers Infrastructure Fund Inc
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.